Blonder Tongue Laboratories Inc - Current report filing (8-K)



 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549



 FORM 8-K


 Current Report Pursuant to Section 13 or 15(d) of
 the Securities Exchange Act of 1934



 Date of Report (Date of earliest event reported): April 18, 2008




  Blonder Tongue Laboratories, Inc.
 (Exact Name of registrant as specified in its charter)



 Delaware 1-14120 52-1611421
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
 of incorporation) Identification No.)



 One Jake Brown Road, Old Bridge, New Jersey 08857
 (Address of principal executive offices) (Zip Code)



 Registrant's telephone number, including area code: (732) 679-4000


 Not Applicable
 (Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:


[_] Written communications pursuant to Rule 425 under the Securities Act (17
 CFR 230.425)


[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
 240.14a-12)


[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
 Exchange Act (17 CFR 240.14d-2(b))


[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
 Exchange Act (17 CFR 240.13e-4(c))











Item 7.01 Regulation FD Disclosure.

 On April 18, 2008 the Company issued a press release announcing that its
Board of Directors made the decision to cease the operation of its wholly-owned
subsidiary, Hybrid Networks, LLC, and liquidate its assets. The press release is
attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by
reference.








Item 9.01. Financial Statements and Exhibits.

 (d) The following exhibits are filed herewith:


 Exhibit 99.1 - Press Release dated April 18, 2008.







 SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


 BLONDER TONGUE LABORATORIES, INC.


 By:  /s/ Eric Skolnik 
 Eric Skolnik
 Senior Vice President and
 Chief Financial Officer
Date: April 21, 2008







 EXHIBIT INDEX




Exhibit No. Description

Exhibit 99.1 Press Release of Blonder Tongue Laboratories, Inc.
 dated April 18, 2008.